Q2 2020 Medivir AB Earnings Call Transcript
Ladies and gentlemen, welcome to the Medivir AB Q2 report 2020. (Operator Instructions)
Today, I am pleased to present Uli Hacksell, CEO. Please begin your meeting.
()-
Thank you, and good afternoon. With me today are Magnus Christensen, who is the Chief Financial Officer; and Linda Basse, our Chief Medical Officer. With that, I will start out by asking Magnus to provide a financial summary of the second quarter.
()-
Thank you, Uli. Please see Slide 3, where you can see the financial summary. You can see the summary for quarter 2 and the half year-end of June. And you can see the turnover for quarter 2 amounts to SEK 4 million, which is very similar to last year and relates to royalty income from Xerclear. Accumulated for the first 6 months of 2020 is SEK 11.4 million, this is almost double last year and it relates to both higher royalty income from Xerclear as well as
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |